Most lately, it's been determined that conolidine and the above derivatives act about the atypical chemokine receptor 3 (ACKR3. Expressed in similar locations as classical opioid receptors, it binds to some big range of endogenous opioids. In contrast to most opioid receptors, this receptor functions like a scavenger and does not activate a 2nd mes